Risk of tuberculosis from arthritis medication examined
Links shared publicly online about this topic.
- 1,930total visits
Risk of tuberculosis from arthritis medication examined
Treatment with anti-tumor necrosis factor agents is recognized as a risk factor for tuberculosis in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis.
View full resource at eurekalert.org
Tags: Arthritis, Arthritis Medication, Rheumatoid Arthritis, Spondyloarthropathy, Ankylosing Spondylitis, Psoriatic Arthritis, Disease and Condition, Drug
Most Recently Shared on July 1, 2009 at 11:21 am By:
Anti-TNF medications create risk of TB in rheumatoid arthritis patients - some worse than others http://ow.ly/gfAX
Medical News: Anti-TNF Therapies Carry Varying Levels of TB Risk - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “LITTLE FALLS, N.J. -- The risk of tuberculosis is higher for patients receiving anti-tumor necrosis factor (anti-TNF) monoclonal antibody therapy than for those receiving soluble TNF receptor therapy” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2009 at 2:46 pm By:
RHEUMATOLOGY• Anti-TNF Therapies Carry Varying Levels of TB Risk (CME/CE) http://tinyurl.com/mugqe2
Advertisement
